Get ready, traders: These stocks are expected to have the biggest moves on earnings this week
Several companies this week are set to report earnings, ranging from chipmakers Super Micro Computer and AMD to health-care giants such as Moderna.
Morgan Stanley banker sees 10 to 15 more tech IPOs in 2024, and a ‘better year’ in 2025
Morgan Stanley, which led the Reddit and Astera Labs IPOs, expects 10 to 15 more tech offerings this year and a “better year” in 2025.
Citi says investors should focus on dividends, lists several buy-rated income stocks to buy
As a lower interest rate environment begins to materialize, investors can turn to dividend-growing stocks for a steady income stream.
Bitcoin and ether drop as investors question the U.S. economy’s strength: CNBC Crypto World
CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry….
Why Eli Lilly’s earnings are no sure thing for traders despite obesity drug momentum
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.
Top Tesla analyst Adam Jonas says Musk’s China visit means ‘he’s back’ and fully committed to EV maker
Morgan Stanley reiterated an overweight rating on Tesla, alongside a $310 per share price target, implying more than 82% upside from Friday’s close.
Dow climbs more than 100 points, Tesla’s 15% pop pushes Nasdaq to close higher: Live updates
Traders are readying for an action-packed week with corporate earnings reports and economic news.
European markets close higher as traders look ahead to Fed meeting; Philips up 29%
European markets closed higher Monday as investors looked ahead to more central bank decisions, earnings and data this week.
L’Occitane’s billionaire owner to take firm private in $1.8 billion deal
As part of the deal, Austrian billionaire Geiger’s investment holding company will pay HK$34 for each share not already owned, representing a 30.8% premium.
